Heron Therapeutics Announces Financial Results for the Three and Nine Months Ended September 30, 2021 and Highlights Recent Corporate Updates

Go back to Heron Therapeutics Announces Financial Results for the Three and Nine Months Ended September 30, 2021 and Highlights Recent Corporate Updates

Heron Therapeutics (HRTX) Tops Q3 EPS by 10c

November 3, 2021 5:32 PM EDT

Heron Therapeutics (NASDAQ: HRTX) reported Q3 EPS of ($0.51), $0.10 better than the analyst estimate of ($0.61). Revenue for the quarter came in at $23.2 million versus the consensus estimate of $25.51 million.

For earnings history and earnings-related data on Heron Therapeutics (HRTX) click here.

... More